Eli Lilly has lowered the price of its weight-loss drug Zepbound for patients paying out of pocket and introduced two new available vial doses.

Zepbound, chemically known as tirzepatide, is the newest weight loss ... medications are under patent, meaning other manufacturers cannot sell generic equivalents until the patent runs out.

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

If you're interested in taking a weight loss drug like Ozempic, Wegovy, or Zepbound, all you have to do is fill out this short form. Ro connects with your provider and comes back to you with a ...

Yet federal regulators recently declared the blockbuster weight-loss drugs Wegovy and Zepbound are no longer ... "We don't want to pull the rug out from under them." Burch added some patients ...

The "Hims and Hers" commercial railed against the weight ... of using GLP-1 medications for weight loss. The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.